Wellbutrin sr and Cyclobenzaprine hydrochloride drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among 26 people who take Wellbutrin sr and Cyclobenzaprine hydrochloride. Common interactions include animal bite among females, and ocular hyperaemia among males.
The phase IV clinical study analyzes what interactions people who take Wellbutrin sr and Cyclobenzaprine hydrochloride have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
26 people who take Wellbutrin sr and Cyclobenzaprine hydrochloride together, and have interactions are studied.
What is Wellbutrin sr?
Wellbutrin sr has active ingredients of bupropion hydrochloride. It is used in depression. Currently, eHealthMe is studying from 12,635 Wellbutrin sr users.
What is Cyclobenzaprine hydrochloride?
Cyclobenzaprine hydrochloride has active ingredients of cyclobenzaprine hydrochloride. It is used in muscle spasms. Currently, eHealthMe is studying from 8,088 Cyclobenzaprine hydrochloride users.
Number of Wellbutrin sr and Cyclobenzaprine hydrochloride reports submitted per year:

Common Wellbutrin Sr and Cyclobenzaprine Hydrochloride drug interactions by gender *:
female:
- Animal bite
- Cellulitis
- Infusion site erythema
- Infusion site pruritus
- Infusion site urticaria
- Seasonal allergy
- Thyroid disorder
- Asthma
- Back disorder
- Fatigue
male:
- Ocular hyperaemia
- Vision blurred
- Memory impairment
- Neurogenic bladder
- Scratch
- Visual field defect
- Visual impairment
- Eye pain
- Eye swelling
- Eyelid irritation
Common Wellbutrin Sr and Cyclobenzaprine Hydrochloride drug interactions by age *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Nasal congestion
- Sinus disorder
- Upper-airway cough syndrome
40-49:
- Blood pressure increased
- Cellulitis staphylococcal
- Deep vein thrombosis
- Dizziness
- Dyspnoea
- Heart rate increased
- Oedema peripheral
- Pain in extremity
50-59:
- Back disorder
- Eye pain
- Eye swelling
- Fatigue
- Flushing
- Foreign body sensation in eyes
- Hepatic lesion
- Hepatic mass
- Hepatic pain
- Impaired healing
60+:
- Animal bite
- Cellulitis
- Asthenia
- Bronchitis
- Dizziness
- Eyelid irritation
- Eyelids pruritus
- Fatigue
- Infusion site rash
- Ocular hyperaemia
Common conditions people have *:
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 34.62%
- Immunodeficiency Common Variable: 4 people, 15.38%
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 11.54%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 7.69%
- Pain: 2 people, 7.69%
- Asthma: 2 people, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Wellbutrin sr and Cyclobenzaprine hydrochloride?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Drug side effects by duration, gender and age:
- Wellbutrin sr side effects (12,635 reports)
- Cyclobenzaprine hydrochloride side effects (8,088 reports)
Common Wellbutrin sr drug interactions:
- Wellbutrin sr and Seroquel: 697 reports
- Wellbutrin sr and Paxil: 579 reports
- Wellbutrin sr and Synthroid: 545 reports
- Wellbutrin sr and Lexapro: 529 reports
- Wellbutrin sr and Aspirin: 507 reports
- Wellbutrin sr and Zoloft: 502 reports
- Wellbutrin sr and Effexor: 495 reports
- Wellbutrin sr and Neurontin: 489 reports
- Wellbutrin sr and Klonopin: 488 reports
- Wellbutrin sr and Xanax: 484 reports
Browse interactions between Wellbutrin sr and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zCommon Cyclobenzaprine hydrochloride drug interactions:
- Cyclobenzaprine hydrochloride and Gabapentin: 1,233 reports
- Cyclobenzaprine hydrochloride and Omeprazole: 1,089 reports
- Cyclobenzaprine hydrochloride and Furosemide: 815 reports
- Cyclobenzaprine hydrochloride and Diphen: 814 reports
- Cyclobenzaprine hydrochloride and Tramadol: 723 reports
- Cyclobenzaprine hydrochloride and Singulair: 633 reports
- Cyclobenzaprine hydrochloride and Aspirin: 613 reports
- Cyclobenzaprine hydrochloride and Pantoprazole sodium: 599 reports
- Cyclobenzaprine hydrochloride and Pantoprazole: 591 reports
- Cyclobenzaprine hydrochloride and Xyrem: 566 reports
Browse interactions between Cyclobenzaprine hydrochloride and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on bupropion hydrochloride and cyclobenzaprine hydrochloride (the active ingredients of Wellbutrin sr and Cyclobenzaprine hydrochloride, respectively), and Wellbutrin sr and Cyclobenzaprine hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Wellbutrin sr and Cyclobenzaprine hydrochloride.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Oxycodone and Communication Disorder - 2 seconds ago
- Ziprasidone Hydrochloride and Famciclovir drug interaction - 18 seconds ago
- Otezla and Acute Myeloid Leukaemia - 35 seconds ago
- Augmentin '125' and Shock Haemorrhagic - 36 seconds ago
- Armour Thyroid and Eating Disorder - 41 seconds ago
- Lanoxin and Methimazole drug interaction - a minute ago
- Evotaz and Wellbutrin drug interaction - a minute ago
- Hydroxyurea and Toviaz drug interaction - a minute ago
- Nubain and Vicoprofen drug interaction - a minute ago
- Midazolam Hydrochloride and Pancytopenia Aggravated - a minute ago